Diabetes
55:691-698,
2006
DOI: 10.2337/diabetes.55.03.06.db05-0771
© 2006 by the American Diabetes Association
Activation of Vascular Protein Kinase C-ß Inhibits Akt-Dependent Endothelial Nitric Oxide Synthase Function in Obesity-Associated Insulin Resistance
Keiko Naruse1,2,
Christian Rask-Madsen1,
Noriko Takahara1,
Sung-woo Ha1,
Kiyoshi Suzuma1,
Kerrie J. Way1,
Judith R.C. Jacobs1,
Allen C. Clermont1,
Kohjiro Ueki1,
Yuzuru Ohshiro1,
Junqing Zhang1,
Allison B. Goldfine1, and
George L. King1
1 Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
2 Department of Internal Medicine, Aichi-Gakuin University, School of Dentistry, Chikusa-ku, Nagoya, Japan
Address correspondence and reprint requests to George L. King, MD, Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Room 4504, Boston, MA 02215. E-mail: george.king{at}joslin.harvard.edu
Abbreviations:
BAEC, bovine aortic endothelial cell; DAG, diacylglycerol; DMEM, Dulbeccos modified Eagles medium; eNOS, endothelial nitric oxide synthase; FFA, free fatty acid; GFP, green fluorescent protein; PI, phosphatidylinositol; PKC, protein kinase C; VEGF, vascular endothelial growth factor
Activation of protein kinase C (PKC) in vascular tissue is associated with endothelial dysfunction and insulin resistance. However, the effect of vascular PKC activation on insulin-stimulated endothelial nitric oxide (NO) synthase (eNOS) regulation has not been characterized in obesity-associated insulin resistance. Diacylglycerol (DAG) concentration and PKC activity were increased in the aorta of Zucker fatty compared with Zucker lean rats. Insulin-stimulated increases in Akt phosphorylation and cGMP concentration (a measure of NO bioavailability) after euglycemic-hyperinsulinemic clamp were blunted in the aorta of fatty compared with lean rats but were partly normalized after 2 weeks of treatment with the PKCß inhibitor ruboxistaurin (LY333531). In endothelial cell culture, overexpression of PKCß1 and -ß2, but not PKC , - , or - , decreased insulin-stimulated Akt phosphorylation and eNOS expression. Overexpression of PKCß1 and -ß2, but not PKC or - , also decreased Akt phosphorylation stimulated by vascular endothelial growth factor (VEGF). In microvessels isolated from transgenic mice overexpressing PKCß2 only in vascular cells, Akt phosphorylation stimulated by insulin was decreased compared with wild-type mice. Thus, activation of PKCß in endothelial cells and vascular tissue inhibits Akt activation by insulin and VEGF, inhibits Akt-dependent eNOS regulation by insulin, and causes endothelial dysfunction in obesity-associated insulin resistance.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Tessari, A. Coracina, L. Puricelli, M. Vettore, A. Cosma, R. Millioni, D. Cecchet, A. Avogaro, A. Tiengo, and E. Kiwanuka
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E776 - E782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev.,
August 1, 2007;
28(5):
463 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ramzy, V. Rao, L. C. Tumiati, N. Xu, R. Sheshgiri, J. Jackman, D. H. Delgado, and H. J. Ross
Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein
J. Thorac. Cardiovasc. Surg.,
May 1, 2007;
133(5):
1137 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Focardi, G. M. Dick, A. Picchi, C. Zhang, and W. M. Chilian
Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate diet
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2093 - H2099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Miyazaki-Akita, T. Hayashi, Q. F. Ding, H. Shiraishi, T. Nomura, Y. Hattori, and A. Iguchi
17beta-Estradiol Antagonizes the Down-Regulation of Endothelial Nitric-Oxide Synthase and GTP Cyclohydrolase I by High Glucose: Relevance to Postmenopausal Diabetic Cardiovascular Disease
J. Pharmacol. Exp. Ther.,
February 1, 2007;
320(2):
591 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|